Where will you be launching your new orphan medicine? You may be confident that your Global market access strategy will support access in key launch markets like the UK, the...
Read More
Discover 11 common problems that may arise when cost-cutting compromises the quality of your systematic literature review.
Which decisions are made at Region level in the NHS in England? How do finances and funding work at this level? And how can industry best support and engage with...
Read More
What actions can you take in light of ISPOR’s top 10 HEOR trends? What impact may these issues have on your HEOR and Market Access strategy?
What do we know about plans and policy for 2024/25? As the expected central operating plan has not (yet) materialised, and with a general election and a potential Labour government...
Read More
What is health economic evaluation and which modelling approaches can be used to support market access activities? In this webinar, our expert health economists explain the key strengths and limitations...
Read More
In this live lecture, Hannah Baker (Consultant – Health Economics) outlines the role health economics plays in modern healthcare.
How can you ensure your product is set up for success from early clinical trials right through to launch and commercialisation? In this Global Whispers webinar we explore best practice...
Read More
In this webinar, our experts explore evidence strategies for medical devices, diagnostics and digital health technologies. Have you established the clinical and economic value of your medical device, diagnostic or...
Read More
How can a digital approach enhance local customer communication, particularly when tools are adapted from existing global materials?
